7:30 AM - 8:10 AM | Sky Lobby and Foyer on the 10th Floor

Registered attendees may stop by the registration desk to collect Forum materials, consult with our Digital Services team on the use of Cavendish IQ for setting partnering meetings, sending messages, profile building, and to grab breakfast, ahead of opening remarks.

8:10 AM - 8:15 AM | J. Michael Moffat, Chairman, Cavendish Global

Cavendish Chairman, Michael Moffat, will open the general session of the Chicago Forum with remarks on the state of the Cavendish network, new announcements from the team and a call for collaboration and impact.

8:15 AM - 9:00 AM | Richard L. Lieber, PhD, CSO and SVP, Shirley Ryan AbilityLab

Details to be announced.

9:00 AM - 10:00 AM | Cavendish Innovation Partners

Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthroughs.

Are you interested in presenting at the Chicago Forum? Contact Gwen Snyder.

10:00 AM - 10:45 AM | Foyer and Auditorium on the 10th Floor

Immediately following Innovation Partner impact presentations, members enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations.

Meetings may be set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder.

10:45 AM - 11:30 PM | Moderated by Jason Cross, PhD, Agraria Technologies

Jason Cross, PhD, together with PwC Director of Pharma R&D, Brian Slizgi; Bright Path Group’s Chief Technology Officer, David Stefanich, will discuss the latest trends around the application of blockchain technology in biohealth, including opportunities and challenges for early-stage companies.

11:30 AM - 12:15 PM | Lili Gil Valletta, CEO & Co-Founder, CIEN+

Award-winning entrepreneur, business strategist, Hispanic market expert and media commentator, Lili Gil Valletta, will discuss the latest applications in data collection and interpretation, to understand and address the unmet needs of patients.

12:15 PM - 1:15 PM | Sky Lobby on the 10th Floor

Break bread with fellow Cavendish members over a casual buffet lunch, surrounded by breathtaking views of Streeterville and Lake Michigan. Cavendish luncheons do not feature keynote speakers, leaving attendees uninterrupted to network, meet and dine.

1:15 PM - 1:45 PM | Moderated by Peter McCrea, President, Cavendish Impact Foundation

In this third installment of a continuing panel series on impact investing, the Cavendish Impact Foundation's Peter McCrea joins philanthropic partner, ImpactAssets' Senior Engagement Officer, Sally Boulter, to discuss the latest strategies in impact investment using philanthropic capital, and how to approach and participate in transactions from the standpoints of donors and innovators.

1:45 - 2:15 PM | Fireside Chat with H. F. “Rick” Pitcairn, CFA, Chief Investment Officer, Pitcairn

Drawing on his experience as CIO of one of the leading family offices in the industry, Rick Pitcairn will discuss key components family offices adhere to when crafting investment strategies for multi-generational families: long-term discipline, asset allocation, diversification, and global market trends.

2:15 PM - 3:15 PM | Cavendish Innovation Partners

Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthroughs.

Are you interested in presenting at the Chicago Forum? Contact Gwen Snyder.

3:15 PM - 4:00 PM | Foyer and Sky Lobby on the 10th Floor

Immediately following Innovation Partner impact presentations, members enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations.

Meetings may be set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder.

4:00 - 4:45 PM | Moderated by Richard L. Lieber, PhD, CSO & SVP, Shirley Ryan AbilityLab

Led by Richard L. Lieber, PhD, and featuring the AbilityLab’s Executive Director for Innovation & Research, David Zembower, PhD; Director of the Regenstein Center for Bionic Medicine, Levi Hargrove, PhD; and VP & Chief of Research Operations, Tim McKula, this panel will highlight the latest innovations emerging out of the AbilityLab and its partner institutions in the region. Panelists will discuss their own journeys in accelerating breakthroughs, while also touching upon their personal successes and challenges in fundraising.

4:45 PM - 5:15 PM | Featuring Beth Rahn, Vice President & Head of Family Capital, McNally Capital; moderated by Steven J. Thayer, JD, Partner, Handler Thayer LLP

Forum programming will close with an exclusive fireside chat with McNally Capital VP and Head of Family Capital, Beth Rahn, together with Steven J. Thayer, Partner at Handler Thayer LLP, a leading Chicago law firm dedicated to rendering superior, technologically current, and innovative professional services to affluent families, family offices and privately-held companies.

5:15 PM - 8:00 PM | Foyer and the Searle Gathering Garden on the 10th Floor

General Session programming will close with an immediate opening of the Evening Cocktail Reception. Cavendish and Forum partners will deliver remarks, repeat the call for greater collaboration, innovation and impact, and highlight the upcoming 2018 Seattle Forum.

Please be sure to join us for a special performance from Cavendish member, Michael Fitzpatrick, acclaimed musician, Founder & Chairman of Earth’s Call, Music Director for the Muhammad Ali Humanitarian Awards and recipient of The Prince Charles Award for Oustanding Musicianship. Mr. Fitzpatrick will also update our community on his latest work and efforts with Earth’s Call.

Additionally, the AbilityLab will be providing exclusive tours for attendees, visiting the facility wet labs and research space, highlighting the AbilityLab's newest capabilities and work.